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Objectives: To analyse comparatively eversion and conventional CEA for later association with restenosis, perioperative 
stroke~death and ipsilateral cerebrovascular events (early, late, disabling and non-disabling). 
Design: Prospective non-randomised clinical study. 
Materials and Methods: A total of 469 patients underwent 514 procedures; 274 (53%) eversion CEA and 240 (47%) 
conventional CEA. Perioperative monitoring was carried out by clinical evaluation under local anaesthesia or by 
transcraniaI Doppler under general anaesthesia. Follow-up was carried out by clinical evaluation and Duplex scanning. 
Results: Clamping time was significantly shorter in the eversion group (25.5++_ 7.4 vs. 28.3 4-10.1 min; p = 0.0001; CI 
A4.40/1.12). The perioperative disabling stroke~death rate was 0.7% for eversion vs. 1.2% for conventional CEA, p = 
0.6; odds ratio (OR), 0.58. There were two early carotid occlusions (within 30 days) in both groups. According to life- 
table analysis, after 3 years the probability of >50%carotid restenosis was significantly lower in the eversion group 
(2.2% vs. 6.9%, p=O.03; relative risk reduction 67%). There were no significant differences between the two groups 
relative to new cerebrovascular events (92% in both groups, p =0.6). Using multivariate analysis (Cox regression), 
eversion CEA, and to a lesser extent standard CEA with patch, appeared to protect the vessel from restenosis. 
Conclusions: The eversion technique was associated with reduced clamping time and probability of restenosis. However, 
because of the nature of a non-randomised study, the present analysis should be confirmed by a multicentre randomised 
trial. 
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Introduction 
Eversion carotid endarterectomy (CEA) was in- 
troduced in the early 1970s, 1 yet has only recently 
been considered as the elective operative procedure 
of choice to prevent restenosis or when redundancy 
and tortuosity are associated with the internal carotid 
artery (ICA). There are no conclusive results sup- 
porting the superiority of the eversion technique com- 
pared to the standard technique. Most literature data 
on follow-up are either missing or incomplete, or are 
based on a small number of patients. In addition, 
lack of adequate controls and of statistical analysis 
contributes to difficulty in drawing definite con- 
clusions. 24 
The main objective of this study was to prospectively 
evaluate patients undergoing CEA and the differences 
occurring in eversion CEA as compared to standard 
* Please address all correspondence to: P. Cao, M.D., Vascular Sur- 
gery Unit, Policlinico Monteluce, 06122 Perugia, Italy. 
CEA, relative to early and late vessel occlusion or 
restenosis and early and late ipsilateral cerebrovascular 
events. 
Patients and Methods 
From 1 January 1992 to 30 September 1994, patients 
undergoing CEA at the vascular surgery unit and 
department of surgery and surgical emergencies at 
Monteluce Hospital, Perugia, Italy, were included in 
a prospective surveillance protocol evaluating surgical 
indications (carotid symptoms: ipsilateral or contra- 
lateral; retinal; vertebro-basilar symptoms; asympto- 
matic), vascular risk factors, surgical techniques 
(eversion, primary closure, patch angioplasty), intra- 
operative details (use of shunt, clamping time), early 
and late neurological events, and vessel restenosis or 
occlusion. 
The study included 469 consecutive patients under- 
going 514 procedures: 274 (53%) eversion CEA and 
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Table 1. Risk factors in 469 patients. 
Eversion Standard 
CEA CEA 
(n =255) (n=214) 
Risk factors Patients % Patients % p value 
Gender 0.9 
Male 194 76 161 75 
Female 61 24 53 25 
Mean age (years) 68 ± 7 68 + 7 0.6 
Alcohol 26 10 19 9 0.7 
Smoking 57 22 42 20 0.5 
Hypertension 148 58 124 58 0.9 
Diabetes 33 13 38 18 0.1 
Dislipidaemia 111 44 75 35 0.07 
Coronary artery 62 24 34 16 0.03 
disease 
Atrial fibrillation 6 2 11 5 0.1 
Contralateral 23 9 31 14 0.08 
occlusion 
Peripheral artery 76 30 49 23 0.1 
obstructive disease 
CT cerebral 103 42 86 43 0.8 
infarction* 
* Only patients with available computed tomographic (CT) scans 
(eversion CEA = 246, standard CEA = 200). 
240 (47%) standard CEA. The study populat ion was 
comprised of 362 (77%) males and 107 (23%) females, 
mean age 68 + 7 (41-85 years). Patient data and pre- 
valence of risk factors are reported in Table 1. These 
risk factors were equally distributed in the two groups 
(eversion and standard CEA), except for coronary 
artery disease (CAD) which was more frequent in the 
eversion group (24% vs. 16%, p = 0.03). Indications for 
surgery and the intraoperative findings are reported 
in Table 2. 
Eversion endarterectomy was performed using the 
technique of Raithel, Berguer, and Vanmaele 2 4: oblique 
transection of the ICA at the bulb, extraction of the 
plaque by eversion of the ICA, endarterectomy of the 
common carotid with previous arteriotomy prolonged 
proximal ly and eversion endarterectomy of the ex- 
ternal carotid artery. Standard CEA was performed 
with selective use of shunt and patch, as previously 
described, mll The choice of the surgical technique was 
left to the discretion of the surgeon (need for shunt, 
redundancy of ICA, etc.). 
Perioperative neurological complications "were 
evaluated at 30 days and were divided into: transient 
ischaemic attack (TIA) and stroke, disabling or non- 
disabling, ipsilateral or contralateral, as previously 
defined} °-12 All deficits lasting more than 6 months 
and significantly modifying the lifestyle of the patient 
were considered as major events. Follow-up was car- 
ried out using a colour Duplex scanner (Aloka SSD 
680). Duplex examinations were scheduled at 1 and 
6 months, then yearly. Restenosis was defined as a 
reduction of at least 50% of the lumen on Duplex 
scanning, according to the criteria of Strandness. ~3 Late 
neurological events (occurring after 30 days) have 
been previously defined, ~°-12 and were assessed by a 
neurologist. Clinical fol low-up was carried out by 
telephone interview when no new events occurred. 
Statistical analysis was performed using the Chi- 
squared test, Fisher's exact test, odds ratio (OR) with 
95% confidence intervals (CI), and Student's t-test. 
Life-table analysis with Kaplan-Meier curves and log 
rank test were used to define the probabil ity of late 
survival, ipsilateral neurological events and restenosis. 
Multivariate analysis using logistic and Cox regression 
(forward stepwise) and hazard ratio (HR) were used 
to exclude the possible confounding effects of different 
clinical variables on the main outcome events (re- 
stenoses and cerebrovascular events). When ipsilateral 
neurological events were used as the main outcome, 
the following clinical variables were considered: age, 
gender, alcohol abuse (>60 g/day) ,  smoking habit, dia- 
betes, peripheral artery obstructive disease (PAOD, 
including aneurysmal disease), dislipidaemia, atrial 
Table 2. Indications and details of surgery. 
Eversion CEA 
(n =274) 
Standard CEA 
(n =240) 
No. % No. % OR 95% CI p value 
Symptomatic* 141 51 
Stroke 54 20 
TIA 87 32 
Shunt 6 2.2 
Patch 
Clamping time (mean)f 25.5 _+ 7.4 min 
107 45 1.32 0.9-1.9 0.1 
46 19 1.04 0.6-1.6 0.5 
61 25 1.4 0.9-2 0.4 
67 28 0.06 0.02-0.14 <0.0001 
118 49 - - - 
28.3 + 10.1 min 4.4-1.1~: 0.0001 
OR = Odds ratio; CI = confidence interval; TIA = transient ischaemic attack. 
* Only ipsilateral symptoms. 
f Only CEAs without shunt: 268 eversion CEA and 173 standard CEA. 
Difference in clamping time between the two groups (min). 
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Table 3. Perioperative complications at 30 days. 
Eversion CEA Standard CEA 
(n = 274) (n ~ 240) 
No. % No. % OR 95% CI p value 
Death 1" 0.4 2t- 0.8 0.4 
Disabling stroke 1{ 0.4 1{ 0.4 0.9 
Any non-disabling stroke 5§ 1.8 8 3.3 0.54 
TIAll 7 2.6 1 0.4 6.27 
0.01-8.4 
0.01-69.2 
0.14-1.90 
0.8-283.5 
0.6 
1 
0.4 
0.07 
* Fatal cerebral haemorrhage. 
f One death resulted from contralateral cerebral haemorrhage and another f om pulmonary embolism. 
{ Ipsilateral stroke. 
§ One contralateral stroke. 
]] All ipsilateral to the CEA. 
Abbreviations a in Table 2. 
fibrillation, hypertension, clamping ischaemia, ip- 
silateral preoperative symptoms, intracranial artery 
stenosis, preoperative cerebral infarction on computed 
tomography (CT), use of shunt, restenosis, and ever- 
sion or standard technique (with or without patch). 
When restenosis was used as the main outcome vent, 
the clinical variables were the same as above (with 
the exception of restenosis, which was a dependent 
variable, CT findings, and intracranial stenosis) with 
the addition of contralateral occlusion. The statistical 
comparison of late events was limited to the first 
36 months (follow-up range 12-54 months, mean 28 
months); the limited number of samples would not 
allow for statistical assessment beyond this time. 
Results 
Mean clamping time (excluding all procedures per- 
formed with shunt) was shorter in the eversion CEA 
group (p=0.0001; 95% CI=A4.40-1.12; Table 2) as 
compared to the conventional CEA group (no patch 
23.3+9.7, patch 32.1+9; p<0.0001). The early com- 
plication rate was similar in the two groups (peri- 
operative disabling stroke/death rate 0.7% vs. 1.2%; 
p=0.6; OR=0.58; 95% CI=0.05-5.12). These results 
were confirmed by multivariate analysis (logistic re- 
gression) of clinical risk factors (p =0.9). In addition 
to the perioperative complications reported in Table 
3, there were four early carotid occlusions, two in each 
group (three were corrected surgically and remained 
patent). The mean duration of follow-up was 28 
months (range 12-54 months): no patient was lost 
at clinical follow-up. No significant differences were 
found between eversion CEA and standard CEA rel- 
ative to late cerebrovascular events, death and myo- 
cardial infarction. There were 28 late deaths: four were 
cerebrovascular (two contralateral ischaemic strokes 
and two contralateral haemorrhages). 
Nineteen patients for whom Duplex scanning was 
unavailable were excluded. Duplex surveillance for 
restenosis was carried out in a cohort of 495 operated 
vessels (264 eversion CEA and 231 standard CEA). 
After 3 years there were five restenoses in the eversion 
CEA group, 14 in the standard CEA group (OR= 0.3; 
95% CI=0.08-0.9; p=0.02), and five late re- 
interventions: one for a false aneurysm in a standard 
case with polytetrafluoroethylene patch and four for 
restenosis (two percutaneous transluminal an- 
gioplasties and two surgical corrections). The dif- 
ference in the restenosis rate was more striking when 
eversion CEA was compared with only primary clos- 
ure procedures: 5/264 vs. 12/113; OR = 0.16; 95% CI = 
0.04-0.51; p= 0.0005). On the contrary, when eversion 
CEA was compared with conventional procedures 
performed with patch the difference disappeared (5/ 
264 vs. 2/118; OR= 1.12; 95% CI=0.18-11.9; p=l ) .  Of 
the 19 restenoses only three were symptomatic (two 
TIA and one stroke). The late ipsilateral neurological 
event rate was 15.8% in the restenosis group and 1.9% 
in the group without restenosis. 
Using Kaplan-Meier curves, the probability of sur- 
vival at 3 years was 91% in the standard CEA group 
as compared to 94.7% in the eversion CEA group (p = 
0.3), while the absence of any ipsilateral neurological 
event (early and late) was 92% in both groups (Fig. 
1). In contrast, the probability of restenosis (calculated 
on 495 vessels by Duplex follow-up) was 2.2% in the 
eversion group and 6.9% in the standard group (p = 
0.03), with an absolute risk reduction of 4.3% and a 
relative risk reduction of 67% (Fig. 2). Using multi- 
variate analysis (Cox regression, Fig. 3), considering 
all the variables, atrial fibrillation was significantly 
related to the appearance of ipsilateral neurological 
events (disabling and non-disabling, early and late). 
The forward stepwise analysis resulted in the fol- 
lowing: HR=4.04; 95% CI=1.4-11.4; p=0.008. Also 
using forward stepwise analysis, symptomatic carotid 
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Fig. 1. Probability of ipsilateral neurological events using Kaplan-Meier curves in patients undergoing standard (© and grey boxes) or 
eversion (x and white boxes) endarterectomy (514 CEA) over a follow-up of 12-54 months (mean 28 months). Log rank test: p=0.6. 
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Fig. 2. Probability of restenosis n patients undergoing standard (~ and grey boxes) or eversion ( x and white boxes) endarterectomy 
(495 CEA) over a follow-up of 12-54 months (mean 28 months). Log rank test: p = 0.03. 
stenosis was  found to be assoc iated w i th  a lower  r isk 
of ips i latera l  events (HR = 0.6; 95% CI = 0.41-0.83; p = 
0.003), whereas  evers ion (HR=0.15;  95% C I=0.05-  
0.45; p =0.0006) and  patch  CEA (HR=0.14;  95% C I= 
0.03-0.64; p=0.01)  had  a s igni f icant ly protect ive  role 
as independent  factors on restenosis  (Fig. 4). 
Discussion 
When CEA is per fo rmed for carot id stenosis,  two 
po ints  shou ld  be cons idered:  the per ioperat ive  major  
compl icat ion  rate and  the durab i l i ty  of the procedure  
in terms of recurrence of stenosis and  symptoms.  
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Sex 
HR 0.77 (0.50-1.30) 
Multivariate analysis 
No neurr 1~°"1 . . . . . . .  New neurological events 
Smoking I 
HR 0.96 (0.40-2.30) L 
Alcohol I 1 
HR 0.53 (0.10-2.30) 
Diabetes t 
HR 1.40 (0.60-3.20) 
Age 
HR 0.98 (0.90-1.10) 
Hypertension I 
HR 0.65 (0.30-1.30) 
Dislipidemia I 
HR 0.54 (0.30-1.20) 
PAOD 
HR 1.99 (0.90-42.0) 
/// 
Atrial fibrillation 
HR 3.70 (1.10-12.30) 
/// 
CT cerebral infarction [ 
HR 0.82 (0.40-16.0) 
/// y 
Clamping ischaemia t 
HR 0.69 (0.30-1.50) 
Shunt* I ~ I 
HR 0.09 (0.01-0.75) U 
Eversion I 
HR 0.85 (0.40-1.70) 
Restenosis I 
HR 2.08 (0.60-7.40) 
Symptomatic I ~ I 
HR 0.54 (0.40-0.80) U 
Intracranial lesions i 
HR 1.53 (0.60-41.0) 
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5 10 
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Fig. 3. Risk of neurological events according to multivariate analysis (Cox regression). Risk reduction plot of the effects of J.5 variables 
for prevention of restenosis n CEA. Horizontal lines indicate 95% CI, rectangles corresponding to the HR of each variable. Values <1 
indicate risk reduction; the values >1 indicate an increase in the probability of neurological events. Values equal to I indicate no differences 
in the results. Statistical significance was obtained Whhn the line expressing 95% CI did not cross the vertical ine, indicating 1. * Not 
significant with forward stepwise. 
Sex 
HR 0.79 (C1 0.40-1.60) 
No re 
Multivariate analysis 
Restenosis 
Smoking r 
]-IR 1.73 (C1 0.60-5.0) 
Alcohol I ~ t 
HR 0.53 (C1 0.06-4.24) 5 
Diabetes 
HR 2.13 (C1 0.67-6.7) 
Age 
HR 0.98 (C1 0.90-1.05) 
Hypertension I 
HR 1.51 (C1 0.50-4.20) 
Dislipidemia L 
HR 1.03 (C1 0.40-2.70) 
PAOD 
HR 3.21 (C1 1.16-8.90) 
Atrial fibrillation* 
HR 7.69 (C1 1.40-42.0) 
Contralateral occlusion* 
HR 4.23 (C1 1.30-13.5) 
Clamping ischaemia 
HR 1.81 (C1 0.60-5.80) 
Shunt I 
HR 0.59 (Cl 0.10-2.50) 
Eversion I~  
HR 0.10 (C1 0.03-0.30) 
Patch 
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Fig. 4. Risk of restenosis according to multivariate analysis (Cox regression). Risk reduction plot of the effects of 15 variables for prevention 
of restenosis in CEA. Horizontal ines indicate 95% CI, rectangles corresponding to the HR of each variable. Values <1 indicate risk 
reduction; the values >1 indicate an increase in the risk of restenosis. Values equal to 1 indicate no differences in the results. Statistical 
significance was obtained when the line expressing 95% CI did not cross ~ the vertical ine, indicating 1. * Not significant with forward 
stepwise. Eur J Vasc Endovasc Surg Vol 14, August 1997 
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Recent clinical trials have clarified the first issue. 14-18 
The benefits of surgery over medical treatment alone 
is strikingly related to the perioperative major com- 
plication rate. The higher the perioperative major event 
rate, the later the survival curves will cross in the 
medical and surgical groups, reducing the benefits of 
surgical intervention. 
The problem of the durability of the procedure and 
recurrence of stenosis remains an open issue, as is 
the possible use of new techniques for endovascular 
treatment of carotid stenosis. These less invasive ap- 
proaches have clear benefits in terms of reduced patient 
discomfort and cost saving, whereas the periprocedure 
risks (in terms of mortality and morbidity) are less 
defined. 19-22 The durability of carotid endovascular 
treatment is also unknown. 
In the literature, the incidence of carotid restenosis 
highly variable (crude rate = 1.5-23°/o), 23 and its clinical 
significance remains unclear. Golledge et al. have re- 
cently questioned the cost-effectiveness of Duplex sur- 
veillance after CEA, 24 leading to the claim that the 
incidence of ipsilateral neurological events in patients 
with vessel restenosis was negligible. This might be 
related to the different characteristics of wall al- 
terations (not true atherosclerotic plaque but intimal 
hyperplasia t least in the first 2-3 years after the 
primary intervention). 25'26 
Eversion endarterectomy with oblique transection 
of the ICA over the bulb has been proposed to reduce 
the risk of restenosisl-9: the oblique suture should 
reduce the effect of intimal hyperplasia on the vessel 
lumen and the risks and complications related to the 
use of patch (harvesting of autologous vein, bulging 
of the bulb, patch disruption, false aneurysms, etc.). 
At the same time, the eversion technique allows the 
correction of distal carotid elongation with dependent 
flow disturbances. In studies addressing this subject 
there are conflicting results: there was no homo- 
geneous control group in six of the eight reports 
reviewed, late events were often reported as the crude 
rate, and only one prospective randomised study with 
a limited number of patients was performed with late 
follow-up (Table 4).4 For these reasons it is very difficult 
to compare the results among these different studies, 
and also with regards to ours. Our perioperative find- 
ings were distributed similarly in the eversion and 
standard CEA groups, although differences in the 
prevalence of CAD (more frequent in the eversion 
group) and in the use of shunts (more frequent in 
the standard group) could suggest a biased selection 
influencing early results. Nevertheless, multivariate 
analysis (logistic regression with forward stepwise) 
confirmed the similarity in the perioperative com- 
plications. Likewise, no differences in early results 
were recorded for perioperative carotid thrombosis 
rates (which could be due to technical errors and the 
type of endarterectomy): two in each group. 
The neurological event rate (including a 30-day 
perioperative interval, TIA, and any stroke) was sim- 
ilar in both groups (8%). When all late ipsilateral 
neurological events were considered (excluding peri- 
operative TIA and strokes), 15.8% were associated 
with vessel restenosis vs. 1.9% with normal patency 
of the ipsilateral carotid: differences were significant 
(p =0.008; OR=9.7). This suggests clinical relevance 
for carotid restenosis in determining late ipsilateral 
neurological events in patients who had undergone 
CEA. Nevertheless, because of the wide confidence 
interval, in order to evaluate how time and to what 
extent restenosis will affect he future of these patients, 
a larger patient cohort and longer follow-up intervals 
are needed. The difference in the carotid restenosis 
rate was evident in eversion and standard CEA, and 
was confirmed by life-table analysis. The difference 
was remarkable for eversion CEA compared to prim- 
ary closure standard CEA, but disappeared when the 
eversion technique was compared with standard CEA 
performed with patch. During late follow-up, one 
patient who had undergone standard CEA with patch 
developed a false aneurysm. This patch-related com- 
plication should be taken into consideration when 
evaluating the two techniques. 
Not surprisingly, of the variety of clinical variables 
examined for their influence on any ipsilateral event, 
after the stringent est of Cox regression and forward 
stepwise analysis, atrial fibrillation was shown to be 
an independent negative predictor, 27-29 whereas, un- 
expectedly, preoperative symptomatic carotid stenosis 
was shown to be a positive independent predictor. 
This could be related to the fact that only ipsilateral 
events were included in the multivariate analysis. 
Furthermore, most of the asymptomatic operated ca- 
rotids were in patients with bilateral disease or contra- 
lateral symptoms: consequently, most of our 
asymptomatic patients were at high risk for developing 
neurological events during follow-up. Eversion CEA, 
and to a lesser extent standard CEA with patch, ap- 
peared to protect the vessel from restenosis. On the 
contrary, PAOD adversely affected this occurrence, 
being a likely marker of severe vascular disease (Fig. 
4). 
In conclusion, in our study eversion CEA was as- 
sociated with reduced clamping time and with a 67% 
relative risk reduction of restenosis in the operated 
vessel at 3 years when compared to conventional 
CEA. With respect o perioperative and late ipsilateral 
neurological events, and early vessel patency, no sig- 
nificant difference with the conventional group was 
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Table 4. Eversion CEA: a review. 
Authors/year Cases no. Perioperative Mean follow-up Restenoses Follow-up events 
stroke/death (months) crude rate (%) crude rate (%) 
(%) 
Retrospective studies 
Kieny 19936 
Raithel 19932 
212 eversion CEA 
(157 follow-up) 
156 standard CEA 
2714 eversion CEA 
(105 follow-up) 
3552 standard CEA 
Koskas 19957 168 eversion CEA 
Entz 1996 s 352 eversion CEA 
Prospective non-randomised studies 
Reigner 19959 65 eversion CEA 
Berguer 19933 
Randomised studies 
Darling III 19955 
Vanmaele 19944 
100 eversion CEA 
76 eversion CEA 
VS. 
61 standard CEA 
102 eversion CEA 
VS. 
98 standard CEA 
(saphenous patch) 
2.4 27.1 (range 6-69) 1.9 4.7 (fatal strokes) 
n.d. 44 13.5 4.5 (fatal strokes) 
2.4 28 (range 12-49) 1.9 1.3 (deaths)+0.6 
(strokes) 
3.8 36 12.3 
2.9 62 (range 5-160) 0.6* 6.7 (ipsilateral 
strokes) 
19' (deaths) 
1.9 6 n.d. n.d. 
1.5 27 (range 18-36) 0* 0* (ipsilateral 
strokes) 
7.5* (deaths) 
1 14 (range 6-21) n.d. n.d. 
1.3 6.2 (range 1-13) n.d. n.d. 
3.3 
4 12 0.98t 5 (deaths, no 
strokes) 
8 2.04i- 6 (deaths, no 
strokes) 
* Actuarial rate. 
f p = 0.524. 
n.d. =not  defined. 
observed. However, differences in the prevalence of 
some risk factors in the two groups, a more frequent 
use of shunt in standard CEA that could affect the 
technical performance, and the surgeon's preference 
for cases more suitable for eversion CEA could have 
influenced the results favouring either of the two 
techniques. Whether eversion CEA is better, the same, 
or less reliable than conventional CEA with or without 
patch remains an open question that can only be 
answered by a prospective randomised study with a 
larger cohort of patients. 
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